Machine learning has moved past its initial experimental phase. In earlier years, development often focused on creating the largest possible models to see what capabilities might appear. Today, the ...

Generative AI models are usually built on deep learning, where multi-layered neural networks scan through endless pieces of ...

Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...

Cancer, Alzheimer’s, and other diseases follow a pathway in the human body. It starts at the molecular and cellular levels, and through a series of complex interactions can lead to the development and ...

Machine learning is a subfield of artificial intelligence, which explores how to computationally simulate (or surpass) humanlike intelligence. While some AI techniques (such as expert systems) use ...

The ability to anticipate what comes next has long been a competitive advantage -- one that's increasingly within reach for developers and organizations alike, thanks to modern cloud-based machine ...

Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study The use of real-world data ...